Bausch + Lomb CorpNYSE:BLCOView on Canadian Exchange
- LAST PRICE14.1700
- TODAY'S CHANGE (%)-0.3700 (-2.5447%)
- Bid / Lots14.1300/ 3
- Ask / Lots14.1700/ 4
- Open / Previous Close14.0900 / 14.5400
- Day Range
- 52 Week Range
- Volume397,101
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLCO |
|---|---|---|
| 09:32 ET | 10822 | 13.76 |
| 09:34 ET | 4224 | 14.23 |
| 09:36 ET | 12669 | 14.14 |
| 09:38 ET | 13129 | 14.365 |
| 09:39 ET | 2476 | 14.38 |
| 09:41 ET | 6395 | 13.92 |
| 09:43 ET | 6628 | 13.91 |
| 09:45 ET | 9347 | 13.7649 |
| 09:48 ET | 11141 | 13.7 |
| 09:50 ET | 10342 | 13.7 |
| 09:52 ET | 12866 | 13.94 |
| 09:54 ET | 3260 | 14.06 |
| 09:56 ET | 2944 | 14.08 |
| 09:57 ET | 7668 | 13.9801 |
| 09:59 ET | 730 | 14.08 |
| 10:01 ET | 23281 | 14.12 |
| 10:03 ET | 1910 | 13.97 |
| 10:06 ET | 2445 | 14.11 |
| 10:08 ET | 1515 | 14.17 |
| 10:10 ET | 3048 | 14.04 |
| 10:12 ET | 2274 | 14.05 |
| 10:14 ET | 4214 | 14.025 |
| 10:15 ET | 3413 | 14.02 |
| 10:17 ET | 3900 | 14 |
| 10:19 ET | 2892 | 14.03 |
| 10:21 ET | 2297 | 14.05 |
| 10:24 ET | 2658 | 14.07 |
| 10:26 ET | 4591 | 14.05 |
| 10:28 ET | 5699 | 14.1 |
| 10:30 ET | 1826 | 14.11 |
| 10:32 ET | 1038 | 14.16 |
| 10:33 ET | 2467 | 14.12 |
| 10:35 ET | 1038 | 14.15 |
| 10:37 ET | 31040 | 14.17 |
| 10:39 ET | 5505 | 14.1604 |
| 10:42 ET | 2475 | 14.195 |
| 10:44 ET | 2763 | 14.19 |
| 10:46 ET | 8922 | 14.19 |
| 10:48 ET | 5886 | 14.24 |
| 10:50 ET | 20535 | 14.28 |
| 10:51 ET | 2900 | 14.29 |
| 10:53 ET | 4931 | 14.295 |
| 10:55 ET | 1400 | 14.27 |
| 10:57 ET | 800 | 14.21 |
| 11:00 ET | 6297 | 14.185 |
| 11:02 ET | 500 | 14.18 |
| 11:04 ET | 3200 | 14.15 |
| 11:06 ET | 131 | 14.14 |
| 11:08 ET | 3290 | 14.14 |
| 11:09 ET | 3790 | 14.03 |
| 11:11 ET | 1962 | 14.0265 |
| 11:13 ET | 800 | 14 |
| 11:15 ET | 1767 | 13.995 |
| 11:18 ET | 1341 | 14 |
| 11:20 ET | 4801 | 14.0599 |
| 11:22 ET | 3709 | 14.01 |
| 11:24 ET | 799 | 14 |
| 11:26 ET | 600 | 14.02 |
| 11:27 ET | 900 | 14.04 |
| 11:29 ET | 913 | 14.035 |
| 11:31 ET | 1900 | 14.05 |
| 11:36 ET | 366 | 14.025 |
| 11:38 ET | 18593 | 14.01 |
| 11:40 ET | 300 | 14.01 |
| 11:42 ET | 4927 | 14.11 |
| 11:44 ET | 1809 | 14.19 |
| 11:45 ET | 938 | 14.15 |
| 11:47 ET | 700 | 14.17 |
Today
DJ Bausch + Lomb Quarterly Loss Widens, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesBausch + Lomb Announces First-Quarter 2024 Results, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesPress Release: Bausch + Lomb Announces First-Quarter 2024 Results, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
Apr 29, 2024
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting, from 7:00AM ET on Monday Apr 29, 2024 by Dow Jones
7:00AM ET on Monday Apr 29, 2024 by Dow Jones
Apr 25, 2024
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes, from 8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bausch + Lomb Corp | 5.1B | -19.1x | --- |
DENTSPLY SIRONA Inc | 6.2B | -48.6x | --- |
Envista Holdings Corp | 3.4B | -32.8x | --- |
Lantheus Holdings Inc | 4.6B | 14.5x | +35.30% |
Haemonetics Corp | 4.7B | 37.4x | +10.35% |
Merit Medical Systems Inc | 4.3B | 47.6x | +14.05% |
Company Information
Bausch + Lomb Corporation is a Canada-based global eye health company. The Company’s Vision Care segment includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over the counter (OTC) eye drops and eye vitamins. The Company’s Ophthalmic Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Its Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. The Company’s brands include PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, and many more.
Contact Information
- Headquarters
- 520 Applewood CrescentVAUGHAN, ON, Canada L4K 4B4
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Brenton Saunders
- Chief Financial Officer, Executive Vice President
- Sam Eldessouky
- President of Ophthalmic Pharmaceuticals
- Andrew Stewart
- Executive Vice President, Chief Legal Officer
- A. Robert Bailey
- Executive Vice President - Research & Development, Chief Medical Officer
- Yehia Hashad
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.1B |
|---|---|
Revenue (TTM) | $4.1B |
Shares Outstanding | 351.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.74 |
Book Value | $19.52 |
P/E Ratio | -19.1x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | 38.1x |
Operating Margin | 3.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
